At the joint ISBT Perth and Blood 2025 meeting, AHF’s Director of Research, Molly Sherwood, took the stage to present the HDFN Consensus Guidelines, reinforcing AHF’s global impact and ongoing committment to collaboration and education in the field of transfusion medicine.

Our Executive Director, Bethany Weathersby, received the 2025 AABB Presidents Award at the AABB Annual Meeting in San Diego. Bethany was recognized for “important advocacy that has advanced the care of women and children affected by blood incompatibility.” Please join us in congratulating Bethany! Read more here.

The Allo Hope Foundation was proud to participate in the Plasma Protein Forum’s “Driving Awareness & Action for Anti-D” session, hosted by the Plasma Protein Therapeutics Association (PPTA). Our Director of Development, Katie Shanahan, joined a diverse panel of experts, including clinicians, industry leaders, and plasma donors, to discuss the global challenges and opportunities surrounding… Read More »

What an honor to attend this extraordinary event celebrating the heroes behind anti-D plasma donation. Each donor’s selfless contributions help protect countless babies from HDFN around the world. Our Director of Development, Katie Shanahan, had the privilege of sharing her personal story, raising awareness of the global burden of HDFN, and highlighting the critical importance… Read More »

Our AHF Ambassador to Kenya had the privilege of speaking at the Bloodsafe Symposium in Nairobi Kenya. The BLOODSAFE Program is a unique initiative that supports research to enhance the availability of safe blood for patients in low or lower-middle-income countries (LLMICs) in Sub-Saharan Africa.

The Allo Hope Foundation teamed up with Dr. Ken Moise and Dr. Tim Bahr at the 2025 Pediatric Academic Societies Meeting in Honolulu. Bethany Weathersby presented “HDFN Disease Realities – A Patient-Led Global Perspective,” highlighting the lived experiences of families, the global burden of disease, critical gaps in care, and the lifesaving impact of timely, evidence-based management. The… Read More »

March 12 is World Alloimmunization and HDFN Awareness Day! We are so excited to have a day dedicated to spreading awareness about alloimmunization and HDFN and celebrating our incredible community. On this day, we celebrate the strength and resiliency of families who have experienced this rare, complicated disease, and the medical communities who support them…. Read More »

SMFM 2025 exceeded our expectations and left us feeling hopeful and inspired. It was a pleasure to reconnect with some of the dedicated providers shaping the future of maternal-fetal medicine, including Dr. Juan Gonzalez (UCSF) and Dr. Saul Snowise (Midwest Fetal Care Center) from our Medical Advisory Board, as well as Dr. Leonardo Pereira (OHSU),… Read More »

Returning to Kenya: Expanding Hope and Advancing Care in 2025 In January 2025, The Allo Hope Foundation returned to Kenya, deepening our commitment to improving care for alloimmunized mothers and babies affected by Hemolytic Disease of the Fetus and Newborn (HDFN). Partnering with our incredible AHF Africa Ambassador, Rose Murage, and an ever-growing network of… Read More »